Abstract:The pharmacological properties of bradykinin receptors were characterized in rat cultured vascular smooth muscle cells (VSMCs) using [3H]-bradykinin as a ligand. Analysis of binding isotherms gave an apparent equilibrium dissociation constant (K(D)) of 1.2 +/- 0.2 nM and a maximum receptor density (Bmax) of 47.3 +/- 4.4 fmol/mg protein. The specific binding of [3H]-bradykinin to VSMCs was inhibited by the B2 receptor-selective agonists (bradykinin and kallidin) and antagonists ([D-Arg0, Hyp3, Thi5, D-Tic7, Oic8]-bradykinin (Hoe 140) and [D-Arg0, Hyp3, Thi(5,8), D-Phe7]-bradykinin) with an order of potency as kallidin = bradykinin = Hoe 140 > [D-Arg0, Hyp3, Thi(5,8), D-Phe7]-bradykinin, but not by a B1 receptor-selective agonist (des-Arg9-bradykinin) and antagonist ([Leu8, des-Arg9]-bradykinin). Stimulation of VSMCs by bradykinin produced a concentration-dependent inositol phosphate (IP) accumulation, and initial transient peak of [Ca2+]i with half-maximal responses (pEC50) were 7.53 and 7.69, respectively. B2 receptor-selective antagonists (Hoe 140 and [D-Arg0, Hyp3, Thi(5,8), D-Phe7]-bradykinin) significantly antagonized the bradykinin-induced responses with pK(B) values of 8.3-8.7 and 7.2-7.9, respectively. Pretreatment of VSMCs with pertussis toxin (100 ng/ml, 24 h) did not alter the bradykinin-induced inositol phosphate accumulation and [Ca2+]i changes in VSMCs. Removal of external Ca2+ led to a significant attenuation of responses induced by bradykinin. Influx of external Ca2+ was required for the bradykinin-induced responses, since Ca2+-channel blockers, nifedipine, verapamil, and Ni2+, partially inhibited the bradykinin-induced IP accumulation and Ca2+ mobilization. These results demonstrate that bradykinin stimulates phosphoinositide hydrolysis and Ca2+ mobilization via a pertussis toxin-insensitive G-protein in rat VSMCs. Bradykinin B2 receptors may be predominantly mediating IP accumulation and subsequently induction of Ca2+ mobilization may function as the transducing mechanism for bradykinin-stimulated contraction of vascular smooth muscle.

Bradykinin mediates the association of collecting duct cells to form migratory colonies, through B2 receptor activation

Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells.

Embryonic and postnatal development of the rat renal interstitium

Bradykinin Potentially Stimulates Cell Proliferation in Rabbit Corneal Endothelial Cells Through the ZO‑1/ZONAB Pathway

Bradykinin mediates myogenic differentiation in murine myoblasts through the involvement of SK1/Spns2/S1P2 axis

Bradykinin‐mediated Ca2+ Signalling Regulates Cell Growth and Mobility in Human Cardiac C‐kit+ Progenitor Cells

Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli

Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells

Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway

The activation of the(Pro)renin receptor (PRR) stimulates fibrotic factors expression independent of b‐catenin signaling pathway in collecting duct cells

Developmental and Cell Fate Analyses Support a Postnatal Origin for the Cortical Collecting System in the Mouse Kidney

Brain Natriuretic Peptide Mitigates TIMP2 Induction and Reinstates Extracellular Matrix Catabolic Activity Via GSK3β Inhibition in Glomerular Podocytes Exposed to a Profibrogenic Milieu.

Role of protein kinase C in beta 2-adrenoceptor function in cultured rat proximal tubule epithelial cells

Effects of bradykinin on the proliferation of rabbit corneal endothelial cells and the expression of tight junction-related proteins ZO-1 and ZONAB

Bradykinin, as a Reprogramming Factor, Induces Transdifferentiation of Brain Astrocytes into Neuron-like Cells

Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells

A novel role of BK potassium channel activity in preventing the development of kidney fibrosis

Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts

A Robust Bioassay of the Human Bradykinin B2 Receptor that Extends Molecular and Cellular Studies: The Isolated Umbilical Vein

Deletion of Β1-Integrin in Collecting Duct Principal Cells Leads to Tubular Injury and Renal Medullary Fibrosis.

Kinin Receptors B1 and B2 Mediate Breast Cancer Cell Migration and Invasion by Activating the FAK-Src Axis